As with any medication, semaglutide may not be suitable for everyone and can have side effects, so it is crucial to consult with our healthcare professionals to determine if it aligns with your individual health profile and aesthetic goals
You may be a candidate for GLP-1 receptor agonists for BED if: You struggle with frequent binge episodes Youve tried diets and therapy with little success You have weight-related health issues like insulin resistance or prediabetes Youre looking for an evidence-based medical approach to weight loss and binge eating disorder help How to Get Started at Pure Medical Spa Chicago At Pure Medical Spa Chicago , our highly-trained staff offers medical evaluations and treatment plans focused on your unique needs
There is an increased risk of overdosing or underdosing GLP-1 medications when switching
Tirzepatide Research# SURPASS program (Type 2 diabetes): Five Phase 3 trials demonstrating superior HbA1c reduction compared to insulin glargine, semaglutide, and insulin degludec SURMOUNT program (Obesity): Phase 3 trials showing up to 20.9% weight loss at 72 weeks FDA approvals : Mounjaro (May 2022) for T2D
Industry analysts, including GlobalData, predict FDA approval for retatrutide in 2027, with a projected sales forecast of $15.6 billion by 2031